(Q36462572)

14 August 2017

1 reference

title

Pharmacological approaches to the treatment of residual symptoms (English)

1 reference

14 August 2017

Maurizio Fava

1

1 reference

PubMed ID

16644769

14 August 2017

language of work or name

English

0 references

publication date

1 May 2006

1 reference

Journal of Psychopharmacology

14 August 2017

1 reference

14 August 2017

20

1 reference

14 August 2017

29-34

1 reference

14 August 2017

3 Suppl

1 reference

Reasons for quitting serotonin reuptake inhibitor therapy: paradoxical psychological side effects and patient satisfaction.

14 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1359786806064325

Antidepressant-induced bruxism successfully treated with gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806064325

Melatonin for the Treatment of Sleep Disturbances in Major Depressive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806064325

Definition and epidemiology of treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806064325

Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806064325

Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806064325

The role and clinical significance of subsyndromal depressive symptoms (SSD) in unipolar major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806064325

Residual symptoms at remission from depression: impact on long-term outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806064325

Short-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806064325

Treatments of depression and the functional capacity to work.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806064325

Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806064325

Trazodone for antidepressant-associated insomnia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806064325

Hypnotics as concurrent medication in depression. A placebo-controlled, double-blind comparison of flunitrazepam and lormetazepam in patients with major depression, treated with a (tri)cyclic antidepressant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806064325

Treatment of insomnia in patients with mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806064325

Effect of continuation treatment on residual symptoms in late-life depression: how well is "well"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806064325

Psychosocial functioning during the treatment of major depressive disorder with fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806064325

Neuropsychological dysfunctions in unipolar nonpsychotic major depressions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806064325

Impaired effortful cognition in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806064325

Changes in adverse events reported by patients during 6 months of fluoxetine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806064325

21 January 2018

Identifiers

DOI

10.1177/1359786806064325

1 reference

14 August 2017

1 reference

PubMed ID

16644769